Parathyroid cancer epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (14 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
The incidence of parathyroid cancer is approximately 0.015 per 100,000 individuals in United States. Parathyroid cancer affects men and women equally. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
In developed countries, the prevalence of parathyroid cancer in United States estimated to be .005% | * In developed countries, the prevalence of parathyroid cancer in United States is estimated to be 0.005%. | ||
===Incidence=== | ===Incidence=== | ||
* In developed countries, the incidence of parathyroid cancer is 0.015 per 100,000 | * In developed countries, the incidence of parathyroid cancer is 0.015 per 100,000 individuals. | ||
=== | ===Age=== | ||
* The incidence of parathyroid cancer increases with age; the median age at diagnosis is between 45 and 51 years. | |||
===Gender=== | ===Gender=== | ||
* The female to male ratio is 1:1. | |||
=== | ===Developed Countries=== | ||
* In the United States, Europe, and Japan, parathyroid carcinoma has been estimated to cause hyperparathyroidism (HPT) in 0.017% to 5.2% of the cases; however, many series report this entity to account for less than 1% of patients with [[primary hyperparathyroidism]].<ref> Parathyroid cancer. Cancer.gov (2015). http://www.cancer.gov/types/parathyroid/hp Accessed on December 29, 2015</ref> | |||
==References== | ==References== | ||
{{Reflist| | {{Reflist|1}} | ||
[[Category: | [[Category:Endocrine system]] | ||
[[Category: | [[Category:Endocrinology]] | ||
[[Category: | [[Category:Otolaryngology]] | ||
[[Category:Disease]] | |||
[[Category:Genetic disorders]] | |||
[[Category:Types of cancer]] | |||
[[Category:Hereditary cancers]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 20:27, 8 January 2016
|
Parathyroid cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Parathyroid cancer epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Parathyroid cancer epidemiology and demographics |
|
Parathyroid cancer epidemiology and demographics in the news |
|
Risk calculators and risk factors for Parathyroid cancer epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
The incidence of parathyroid cancer is approximately 0.015 per 100,000 individuals in United States. Parathyroid cancer affects men and women equally.
Epidemiology and Demographics
Prevalence
- In developed countries, the prevalence of parathyroid cancer in United States is estimated to be 0.005%.
Incidence
- In developed countries, the incidence of parathyroid cancer is 0.015 per 100,000 individuals.
Age
- The incidence of parathyroid cancer increases with age; the median age at diagnosis is between 45 and 51 years.
Gender
- The female to male ratio is 1:1.
Developed Countries
- In the United States, Europe, and Japan, parathyroid carcinoma has been estimated to cause hyperparathyroidism (HPT) in 0.017% to 5.2% of the cases; however, many series report this entity to account for less than 1% of patients with primary hyperparathyroidism.[1]
References
- ↑ Parathyroid cancer. Cancer.gov (2015). http://www.cancer.gov/types/parathyroid/hp Accessed on December 29, 2015